Voyager Therapeutics, Inc. (VYGR) Net Income by Year
Voyager Therapeutics, Inc. reported a net loss of $119.7M in fiscal year 2025. This represents a decrease of 84.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $107.7M net loss. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Voyager Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VYGR Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
VYGR Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Voyager Therapeutics, Inc. financials
Frequently Asked Questions
What was Voyager Therapeutics, Inc.'s net income in fiscal year 2025?
Voyager Therapeutics, Inc. reported a net loss of $119.7M in fiscal year 2025.
How fast is Voyager Therapeutics, Inc.'s net income growing?
Voyager Therapeutics, Inc. (VYGR) net income fell by 84.2% year over year, from -$65.0M to -$119.7M in fiscal year 2025.
What is Voyager Therapeutics, Inc.'s net income over the last twelve months?
Voyager Therapeutics, Inc. (VYGR) reported a $107.7M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Voyager Therapeutics, Inc.'s net income changed over the years?
Across the 12 fiscal years this page covers, Voyager Therapeutics, Inc. (VYGR) net income went from -$16.3M in fiscal year 2014 to -$119.7M in fiscal year 2025.
What was Voyager Therapeutics, Inc.'s net income in the most recent quarter?
Voyager Therapeutics, Inc. (VYGR) reported -$24.5M in net income in Q2 2026. This represents an increase of 26.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Voyager Therapeutics, Inc. (VYGR) reported on that line in every period on record.